Thyme Care’s Post

Every oncology organization wants to give patients more time to focus on what matters most—their journey toward better health. Watch our webinar with Unlimited Systems to learn how our integration lets patients complete intake and pay their financial responsibility on their mobile device from the comfort of their home: https://bit.ly/3Ugv4h6

Upcoming Webinar - Using Mobile Visits in an Interstitial Lung Disease Study: A PI’s Perspective Key members from the University of Pittsburgh and PCM TRIALS - Quality Mobile Research will join to discuss the implementation, challenges, and successes of bringing clinical trials directly to patients’ homes. Attendees will gain insights into the successful adoption of DCT strategies and receive actionable advice for those interested in implementing them in their own studies. As the registration window is closing soon, register now and be apart of this engaging discussion. Speakers: 📣 Rohit Aggarwal - Medical Director - University of Pittsburgh 📣 Sol Dominguez - Trial Project Director - University of Pittsburgh 📣 Sara Bailey - Snr Clinical Project Manager - PCM Trials 📣 Ellen Weiss - Strategy, Decentralized Trials - PCM Trials 📅 27th August 2024 🕔 3pm London / 10am New York 👉 Click here to register for free - https://lnkd.in/dxPcJy-u #clinicaltrials #dct #decentralizedtrials #decentralizedclinicaltrials #lungdisease

Research News! 🌟 At the Bateman Horne Center, we’re committed to advancing treatments for chronic illnesses. Our latest blog highlights promising results from two clinical trials: 🔬 RESTORE ME Trial: 📉 Fatigue reduced by 27% with oxaloacetate—a quality of life improvement for ME/CFS patients! 💊 Long COVID Trial: Low-dose valacyclovir + celecoxib showed meaningful fatigue reduction for Long COVID sufferers. Your support makes this life-changing research possible. 💙 Together, we’re driving real progress toward better care and treatments. 📖 Read the blog from BHC's Director of Research, Suzanne Vernon, PhD, here: https://loom.ly/YVzZ95A #ClinicalTrials #MECFS #LongCOVID

SPHERE's Executive Director, Professor Chris White, was recently invited to attend the Crohn's Colitis Cure annual meeting where progress toward establishing a community-led cloud-based medical record for its 15000+ consumers with inflammatory bowel disease was presented. This collaboration represents a significant step forward in enhancing specialist engaged care to patients with Inflammatory Bowel Disease (#IBD) wherever they are across the globe, while providing a robust resource of patient #realworddata and insights. In the complex world of IBD care this kind of comprehensive data via public participation is a game-changer. It opens new avenues for collaborative research, implementing and identifying effective therapies and management —and ultimately, a cure. We are excited to see how this integration will propel Crohn's Colitis Cure's mission and contribute to transforming the lives of those affected by IBD. More importantly, SPHERE recognises the value of integrating Crohn's Colitis Cure's data with hospital-based records and other models of community led and specialist engaged models that could follow this paradigm. Joseph P. Health Translation SA Georgina Hold Bill Petch Professor Jane M Andrews Susan Connor #crohns #crohnscolitiscure #inflammatoryboweldisease

Ihab Abumuhor, MLS(ASCP)CM SBB uses the Negotiation and Advocacy Toolkit to improve every aspect of patient care and in the laboratory: "The lab's contributions are integral to many hospital process improvements, including reducing length of stay, and assisting physicians in making treatment decisions for cancer, diabetes, cardiac conditions, population health, test utilization, and more. Effectively communicating this information to C-suite executives is crucial for building trust, which is essential when requesting resources like state-of-the-art equipment.” See how the Toolkit can be useful for your team by visiting: https://bit.ly/3VCdOmd

In July 2023, Leqembi® became the first disease-modifying treatment to receive traditional approval from the FDA. Making this new therapy available has required health systems to pivot and collaborate to ensure access and safety. On June 27, the webinar “A new era of treatment: Lessons in anti-amyloid care pathways” will review available treatments and therapies for Alzheimer's disease, key considerations for ensuring safe access to new therapies and nonpharmacologic strategies for caring for and treating Alzheimer's and related dementias. It’s presented in partnership with HANYS and New York Presbyterian/Columbia University. https://bit.ly/4bDVr6U

A brilliant piece of research by a brilliant team led by fellow advocate Siobhan Gaynor. 99.5% of patients surveyed wanted access to their medical records! We need to accelerate the digital health record

In case you missed our recent #Dementia Academy webinar, you can now watch this on demand on our website: System readiness for DMTs in Alzheimer's disease New drug treatments for #Alzheimers are now becoming available, posing a challenge for integration into existing healthcare systems. Understanding public attitudes toward these treatments is essential. Prof Iracema Leroi and Dr George Crowther explore public perceptions of disease-modifying therapies (DMTs) for Alzheimer's, including awareness of prevention and treatment options, perceived benefits and risks, and willingness to pay. We outline how to ascertain numbers of potential eligible patients for DMTs, the key components needed to ensure a health system is prepared to deliver these treatments, and insights into both public and patient acceptance of the therapies. Watch the webinar: https://lnkd.in/eJCJKe2n

Today, we honor rare disease patients, researchers, sponsors, and alliance members for their dedication and hard work in combating rare diseases worldwide. Your efforts inspire hope, progress, and the pursuit of better treatments. We invite rare disease patients to join us on this crucial journey. By participating in clinical trials, you advance research, discover new therapies, and bring hope to many. Your courage fuels medical breakthroughs. Let’s continue to champion diversity, inclusion, equity, and accessibility in clinical trials. Together, we can create a brighter future. Join us and learn more about participating in clinical trials at: https://lnkd.in/gq8_m_-F Harsha K Rajasimha Nisha Venugopal Ramya T karur Narayanan Govindarajan Reena Kartha Indo US Organization for Rare Diseases (IndoUSrare) #ClinicalTrialsDay #RareDiseaseWarriors #clinicaltrialsday2024 #CTD2024 #clinicaltrials #rarediseases #patientcare #togetherwecan #bridge4rare #bridgingrare

News from our collaborators! From Bateman Horne Center of Excellence: At the Bateman Horne Center, we’re committed to advancing treatments for chronic illnesses. Our latest blog highlights promising results from two clinical trials: 🔬 RESTORE ME Trial: 📉 Fatigue reduced by 27% with oxaloacetate—a quality of life improvement for ME/CFS patients! 💊 Long COVID Trial: Low-dose valacyclovir + celecoxib showed meaningful fatigue reduction for Long COVID sufferers. 📖 Read the blog from BHC's Director of Research, Suzanne Vernon, PhD, here: https://loom.ly/YVzZ95A #ClinicalTrials #MECFS #LongCOVID